Malabsorption Syndromes
12
2
2
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
8%
1 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (12)
Long-term Health Outcomes of Screen Detected and Potential Celiac Disease Patients
Safety and Efficacy of Crofelemer in Adult Patients With Short Bowel Syndrome and Intestinal Failure (SBS-IF) Without Colon-in-continuity (CIC)
Immune Responses to Gluten
Effects of Home Gluten Immunogenic Peptide Testing on Children With Celiac Disease
A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD)
Bioequivalence Study of Nexvax2 in Subjects With Celiac Disease
A Study of the Efficacy and Tolerability of Pancrelipase Microtablet (MT) Capsules for the Treatment of Cystic Fibrosis-dependent Exocrine Pancreatic Insufficiency
Vitamin D Substitution for Patients With Chronic Pancreatitis and Malabsorption
Validation of Breath Tests in Diagnosing Small Bowel Bacterial Overgrowth
Plasma Citrulline Concentration in Tropical Enteropathy
The Early Nasojejunal Tube to Meet Energy Requirements in Intensive Care (ENTERIC) Study
Citrulline: A Plasmatic Marker to Assess and Monitor Small Bowel Crohn's Disease Patients